These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32592899)

  • 1. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption.
    Zhu Y; Liang X; Lu C; Kong Y; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H
    Int J Pharm; 2020 Aug; 586():119569. PubMed ID: 32592899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation.
    Patel P; Patel M
    Eur J Pharm Sci; 2021 Apr; 159():105715. PubMed ID: 33453388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine.
    Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q
    Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways.
    Zhu Y; Fu Y; Zhang A; Wang X; Zhao Z; Zhang Y; Yin T; Gou J; Wang Y; He H; Tang X
    Eur J Pharm Sci; 2022 Jan; 168():106047. PubMed ID: 34687899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
    Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
    Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
    Wu L; Zhao L; Su X; Zhang P; Ling G
    Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.
    Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q
    Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
    Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
    Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
    Yin J; Hou Y; Yin Y; Song X
    Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study.
    Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X
    Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eudragit L100-coated nintedanib nanocrystals improve oral bioavailability by reducing drug particle size and maintaining drug supersaturation.
    Che J; Fu Y; Li Y; Zhang Y; Yin T; Gou J; Tang X; Wang Y; He H
    Int J Pharm; 2024 Jun; 658():124196. PubMed ID: 38703933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
    Zhang T; Chen J; Zhang Y; Shen Q; Pan W
    Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model.
    Li J; Yang M; Xu W
    Drug Des Devel Ther; 2018; 12():2241-2248. PubMed ID: 30050285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.
    Dong Z; Iqbal S; Zhao Z
    AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.